You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. MicroLens Hyperspectral Imager for Standoff Chemical Detection

    SBC: NANOHMICS INC            Topic: CBD171002

    For standoff chemical identification applications, the longwave infrared has several key lines for spectral discrimination.Unfortunately, most hyperspectral systems are quite large, making them unwieldy.Nanohmics proposes to develop a chip-scale longwave infrared hyperspectral imaging technology.The weight and packaging volume will be dominated by the fore-optics instead of the spectroscopy soluti ...

    SBIR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  2. High Sensitivity, Low Complexity, Multiplexed Diagnostic Devices

    SBC: Paratus Diagnostics            Topic: CBD152005

    Our goal is to provide the Department of Defense with a reliable, point-of-need diagnostic device that is field-deployable, appropriatelysensitive, and can be easily adapted for detection of a variety of biological targets that are of interest to the defense community. Phase I of thisproject was for the initial demonstration and development of our low-cost personal diagnostic platform (referred to ...

    SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense
  3. High-affinity monoclonal antibodies that target Burkholderia Polysaccharide

    SBC: DXDISCOVERY INC            Topic: CBD14105

    The purpose of this contract is to develop high affinity antibodies that are specific to Burkholderia surface expressed polysaccharides. These monoclonal antibodies (mAbs) can then be used to develop diagnostics and therapeutics for melioidosis and glanders; two infectious diseases caused by the Tier 1 biothreats Burkholderia pseudomallei and mallei, respectively. The SBIR funded work to date deve ...

    SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government